Overcoming diverging regulatory expectations to bring CGTs to market
Drug Discovery World
AUGUST 14, 2023
While CGT is still an emerging market, its growth has accelerated over the last five years, resulting in a wave of products approved by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Driven by the rapid pace of innovation, the market for CGTs is expected to grow from $4.4 billion in 2020 to $15.5
Let's personalize your content